vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and Palomar Holdings, Inc. (PLMR). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $253.4M, roughly 1.1× Palomar Holdings, Inc.). On growth, Palomar Holdings, Inc. posted the faster year-over-year revenue change (62.7% vs 4.7%). Palomar Holdings, Inc. produced more free cash flow last quarter ($409.0M vs $3.3M). Over the past eight quarters, Palomar Holdings, Inc.'s revenue compounded faster (46.2% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.
EHAB vs PLMR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $253.4M |
| Net Profit | $-38.7M | — |
| Gross Margin | — | — |
| Operating Margin | -12.3% | 28.7% |
| Net Margin | -14.3% | — |
| Revenue YoY | 4.7% | 62.7% |
| Net Profit YoY | 15.9% | — |
| EPS (diluted) | $-0.76 | $2.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $253.4M | ||
| Q3 25 | $263.6M | $244.7M | ||
| Q2 25 | $266.1M | $203.3M | ||
| Q1 25 | $259.9M | $174.6M | ||
| Q4 24 | $258.2M | $155.8M | ||
| Q3 24 | $253.6M | $148.5M | ||
| Q2 24 | $260.6M | $131.1M | ||
| Q1 24 | $262.4M | $118.5M |
| Q4 25 | $-38.7M | — | ||
| Q3 25 | $11.1M | $51.5M | ||
| Q2 25 | $5.2M | $46.5M | ||
| Q1 25 | $17.8M | $42.9M | ||
| Q4 24 | $-46.0M | — | ||
| Q3 24 | $-110.2M | $30.5M | ||
| Q2 24 | $-200.0K | $25.7M | ||
| Q1 24 | $200.0K | $26.4M |
| Q4 25 | -12.3% | 28.7% | ||
| Q3 25 | 6.4% | 27.4% | ||
| Q2 25 | 6.3% | 29.5% | ||
| Q1 25 | 6.1% | 30.8% | ||
| Q4 24 | -16.0% | 28.9% | ||
| Q3 24 | -38.6% | 25.9% | ||
| Q2 24 | 4.3% | 25.5% | ||
| Q1 24 | 4.9% | 29.0% |
| Q4 25 | -14.3% | — | ||
| Q3 25 | 4.2% | 21.0% | ||
| Q2 25 | 2.0% | 22.9% | ||
| Q1 25 | 6.8% | 24.6% | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | -43.5% | 20.5% | ||
| Q2 24 | -0.1% | 19.6% | ||
| Q1 24 | 0.1% | 22.3% |
| Q4 25 | $-0.76 | $2.05 | ||
| Q3 25 | $0.22 | $1.87 | ||
| Q2 25 | $0.10 | $1.68 | ||
| Q1 25 | $0.35 | $1.57 | ||
| Q4 24 | $-0.92 | $1.29 | ||
| Q3 24 | $-2.20 | $1.15 | ||
| Q2 24 | $0.00 | $1.00 | ||
| Q1 24 | $0.01 | $1.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $106.9M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $942.7M |
| Total Assets | $1.2B | $3.1B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $106.9M | ||
| Q3 25 | $56.9M | $111.7M | ||
| Q2 25 | $37.1M | $81.3M | ||
| Q1 25 | $39.5M | $119.3M | ||
| Q4 24 | $28.4M | $80.4M | ||
| Q3 24 | $45.7M | $86.5M | ||
| Q2 24 | $28.5M | $47.8M | ||
| Q1 24 | $36.5M | $61.4M |
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $942.7M | ||
| Q3 25 | $566.8M | $878.1M | ||
| Q2 25 | $552.4M | $847.2M | ||
| Q1 25 | $543.2M | $790.4M | ||
| Q4 24 | $523.5M | $729.0M | ||
| Q3 24 | $566.1M | $703.3M | ||
| Q2 24 | $674.3M | $532.6M | ||
| Q1 24 | $672.3M | $501.7M |
| Q4 25 | $1.2B | $3.1B | ||
| Q3 25 | $1.2B | $2.9B | ||
| Q2 25 | $1.2B | $2.8B | ||
| Q1 25 | $1.2B | $2.4B | ||
| Q4 24 | $1.2B | $2.3B | ||
| Q3 24 | $1.3B | $2.3B | ||
| Q2 24 | $1.4B | $2.0B | ||
| Q1 24 | $1.4B | $1.9B |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $409.1M |
| Free Cash FlowOCF − Capex | $3.3M | $409.0M |
| FCF MarginFCF / Revenue | 1.2% | 161.4% |
| Capex IntensityCapex / Revenue | 0.4% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $700.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $409.1M | ||
| Q3 25 | $37.8M | $83.6M | ||
| Q2 25 | $10.6M | $120.9M | ||
| Q1 25 | $17.9M | $87.2M | ||
| Q4 24 | $-4.1M | $261.2M | ||
| Q3 24 | $28.4M | $100.3M | ||
| Q2 24 | $9.6M | $55.1M | ||
| Q1 24 | $17.3M | $33.1M |
| Q4 25 | $3.3M | $409.0M | ||
| Q3 25 | $36.2M | $83.6M | ||
| Q2 25 | $8.7M | $120.8M | ||
| Q1 25 | $17.6M | $87.1M | ||
| Q4 24 | $-4.7M | $260.9M | ||
| Q3 24 | $27.7M | $100.1M | ||
| Q2 24 | $8.9M | — | ||
| Q1 24 | $15.5M | — |
| Q4 25 | 1.2% | 161.4% | ||
| Q3 25 | 13.7% | 34.2% | ||
| Q2 25 | 3.3% | 59.4% | ||
| Q1 25 | 6.8% | 49.9% | ||
| Q4 24 | -1.8% | 167.5% | ||
| Q3 24 | 10.9% | 67.4% | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 5.9% | — |
| Q4 25 | 0.4% | 0.1% | ||
| Q3 25 | 0.6% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.2% | 0.2% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 0.7% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | 1.63× | ||
| Q2 25 | 2.04× | 2.60× | ||
| Q1 25 | 1.01× | 2.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 2.14× | ||
| Q1 24 | 86.50× | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
PLMR
Segment breakdown not available.
